Evidence map›Paper›PMID 37202513›Full record

ReviewNature aging2023

Social participation and risk of developing dementia.

Andrew Sommerlad, Mika Kivimäki, Eric B Larson, Susanne Röhr, Kokoro Shirai, Archana Singh-Manoux, Gill Livingston

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
48.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 176 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The social environment and cognitive aging over the life course: laying out critical concepts and research gaps.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  10. Article
  11. Association between intrinsic capacity and dementia risk in older Mexicans.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 8 countries.

Andrew SommerladDivision of Psychiatry, University College London, London, UK. a.sommerlad@ucl.ac.uk.ORCID http://orcid.org/0000-0002-8895-7055
Mika KivimäkiDivision of Psychiatry, University College London, London, UK.ORCID http://orcid.org/0000-0002-4699-5627
Eric B LarsonUniversity of Washington Schools of Medicine and Public Health, Seattle, WA, USA.
Susanne RöhrSchool of Psychology, Massey University, Manawatu, New Zealand.
Kokoro ShiraiDepartment of Social Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Archana Singh-ManouxDivision of Psychiatry, University College London, London, UK.ORCID http://orcid.org/0000-0002-1244-5037
Gill LivingstonDivision of Psychiatry, University College London, London, UK.ORCID http://orcid.org/0000-0001-6741-5516
Délégation Paris 5 · FRThe London College · GBThe University of Osaka · JPTrinity College Dublin · IEUniversity College London · GBUniversity of Helsinki · FIUniversity of Washington · US

Funding

Education, socioeconomic status and Aging: transitions from multimorbidity to functional limitations and mortalityR01AG056477 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2018 to 2022
$2.8M
Role of mid- and late-life risk factors in social inequalities in Alzheimer's Disease and Related DementiasRF1AG062553 · NIA · INSERM PARIS 5 · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2019 to 2019
$1.5M
Medical Research Council MRC S011676/1Medical Research Council MR/R024227/1Medical Research Council MR/S011676/1Medical Research Council R024227/1NIA NIH HHS R01 AG056477NIA NIH HHS RF1 AG062553
6 · The paper itself

Abstract

The increasing number of people with dementia globally illustrates the urgent need to reduce dementia's scale and impact. Lifetime social participation may affect dementia risk by increasing cognitive reserve, and through brain maintenance by reducing stress and improving cerebrovascular health. It may therefore have important implications for individual behavior and public health policy aimed at reducing dementia burden. Observational study evidence indicates that greater social participation in midlife and late life is associated with 30-50% lower subsequent dementia risk, although some of this may not be causal. Social participation interventions have led to improved cognition but, partly due to short follow-up and small numbers of participants, no reduction in risk of dementia. We summarize the evidence linking social participation with dementia, discuss potential mechanisms by which social participation is likely to reduce and mitigate the impact of neuropathology in the brain, and consider the implications for future clinical and policy dementia prevention interventions.

Indexed as

Cognitive ReserveDementiaBrainCognitionHumansObservational Studies as TopicSocial Participation

Identifiers

PMID37202513
OpenAlexW4377020087

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.